Casdin Capital
Casdin Capital invests in all aspects of the life sciences revolution, partnering with companies across Healthcare, Biotechnology, Synthetic Biology, and Technology. Their investment strategy focuses on big markets, great ideas, strong teams, and a long-term perspective. They aim to create value and open new opportunities through patience and strong relationships.
📥 Buy Full VC Dataset
Offices: New York (United States)
Investment Stages: Series A, Series B, Series C
Markets: Healthcare, Biotechnology, Synthetic Biology, Technology
Founded Year: 2012
Investor Type: Venture Capital
Portfolio Companies: 23andMe, 4D Molecular Therapeutics, 908 devices, A2 Biotherapeutics, AbSci, Adaptive Biotechnologies, Affinia, Alector, Aledade, AmplifyBio
Website: https://casdincapital.com
Team Page: https://casdincapital.com/team/
LinkedIn: https://www.linkedin.com/company/casdin-capital-llc
Twitter: https://twitter.com/cascapital
Crunchbase: https://www.crunchbase.com/organization/casdin-capital
Comments
No comments yet. Be the first to comment!